Sonoma Pharmaceuticals, Inc. (SNOA) Financials
SNOA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 14.6 million | 7.9 million |
2023-09-30 | 13.6 million | 8.0 million |
2023-06-30 | 15.9 million | 8.7 million |
2023-03-31 | 16.2 million | 8.3 million |
SNOA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -1.1 million | 140000 |
2023-09-30 | -1.2 million | 130000 |
2023-06-30 | -232000 | 177000 |
2023-03-31 | -2.6 million | 100000 |
SNOA Net Income
No data available :(
SNOA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 2.4 million | - | 341000 |
2023-09-30 | 2.1 million | - | 350000 |
2023-06-30 | 3.5 million | - | 354000 |
2023-03-31 | 3.8 million | - | 418000 |
SNOA Shares Outstanding
SNOA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1000 | 601000 | 1.7 million | - |
2023-09-30 | 2000 | 536000 | 1.7 million | - |
2023-06-30 | 17000 | 325000 | 2.1 million | - |
2023-03-31 | 190000 | 201000 | 1.7 million | 156000 |
SNOA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 3.1 million | 1.7 million |
2023-09-30 | 2.7 million | 1.7 million |
2023-06-30 | 3.4 million | 2.2 million |
2023-03-31 | 3.0 million | 2.2 million |
SNOA
Price: $0.16
52 week price:
Earnings Per Share: -0.82 USD
P/E Ratio: -0.19
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 313242
Ebitda: -12.7 millionMarket Capitalization: 2.7 million